[Back]
Univ.-Prof. Dipl. oec. troph. Dr. Ina Bergheim, Privatdoz.
T: +43-1-4277-54981
Winter term 2025
301870 PR Scientific Practice in Molecular Biology I
330019 VO Biochemie
330028 UE Übungen zu Methoden der experimentiellen Ernährungsforschung
330053 SE Wissenschaftliches Schreiben-Bachelorarbeit Unterrichtsfach Haushaltsökonomie und Ernährung
330060 SE Seminar Vertiefende Humanernährung
330062 VO Methoden der experimentellen Ernährungsforschung
330063 SE Wissenschaftliches Schreiben- Bachelorarbeit, 10ECTS - für Bachelorstudierende Ernährungswissenschaften Version 2013
330105 VO Ernährung als Wissenschaft - Teil der STEOP im Bachelor EW Version 2013 und Bachelor Lehramt
330115 VO Angewandte und Vertiefende Humanernährung
330120 UE Übungen zu molekularen Arbeitsmethoden in der Ernährungswissenschaft UE 12ECTS
580002 SE PhaNuSpo - Scientific Lectures
Summer term 2025
330021 UE Übungen zur experimentellen Humanernährung
330053 SE Wissenschaftliches Schreiben-Bachelorarbeit Unterrichtsfach Haushaltsökonomie und Ernährung
330063 SE Wissenschaftliches Schreiben- Bachelorarbeit, 10ECTS - für Bachelorstudierende Ernährungswissenschaften Version 2013
330105 VO Ernährung als Wissenschaft - Teil der STEOP im Bachelor EW Version 2013 und Bachelor Lehramt
330112 VO Anatomie und Histologie
330120 UE Übung zur Ernährung und Immunfunktion
580002 SE PhaNuSpo - Scientific Lectures
Winter term 2024
330019 VO Biochemie
330028 UE Übungen zu Methoden der experimentiellen Ernährungsforschung
330053 SE Wissenschaftliches Schreiben-Bachelorarbeit Unterrichtsfach Haushaltsökonomie und Ernährung
330060 SE Seminar Vertiefende Humanernährung
330062 VO Methoden der experimentellen Ernährungsforschung
330063 SE Wissenschaftliches Schreiben- Bachelorarbeit, 10ECTS - für Bachelorstudierende Ernährungswissenschaften Version 2013
330105 VO Ernährung als Wissenschaft - Teil der STEOP im Bachelor EW Version 2013 und Bachelor Lehramt
330115 VO Angewandte und Vertiefende Humanernährung
330120 UE Übungen zu molekularen Arbeitsmethoden in der Ernährungswissenschaft UE 12ECTS
580002 SE PhaNuSpo - Scientific Lectures
1 - 20 out of 90
Rajcic D, da Silva BP, Baranovskyi T, Simbrunner B, Hofer BS, Hoebinger C et al. IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver Disease. Liver international. 2025 Oct;45(10):e70356. doi: 10.1111/liv.70356
Kromm F, Baumann A, Sánchez De Medina Hernández V, Brandt A, Staltner R, Bergheim I. Oral supplementation of melatonin attenuates the onset of alcohol-related liver disease. Journal of molecular medicine. 2025 Oct;103(8):1219–1230. Epub 2025 Aug 7. doi: 10.1007/s00109-025-02583-4
Kromm F, Bozkir HÖ, Brandt A, Yergaliyev T, Camarinha-Silva A, Bergheim I. Aging-related decline in the liver and brain is accelerated by refined diet consumption. GeroScience. 2025 Sept 26. Epub 2025 Sept 26.
Staltner R, Csarmann K, Geyer A, Nier A, Baumann A, Bergheim I. Fructose intake enhances lipoteichoic acid-mediated immune response in monocytes of healthy humans. Redox biology. 2025 Sept;85(2025):103729. doi: 10.1016/j.redox.2025.103729
Burger K, Trauner M, Bergheim I. Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review. Cell Stress. 2025 Jun 24;9(1):49-64. doi: 10.15698/cst2025.06.305
Baumann A, Freutsmiedl V, Jelleschitz J, Staltner R, Brandt A, Schachner D et al. Honokiol, a Neolignan from Magnolia officinalis, Attenuated Fructose-Induced Hepatic Fat Accumulation by Improving Intestinal Barrier Function in Mice. The Journal of Nutrition. 2025 Apr;155(4):1173-1182. doi: 10.1016/j.tjnut.2025.02.017
Burger K, Jung F, Staltner R, Csarmann K, Schweiger K, Brandt A et al. A weekly 4-methylpyrazole treatment attenuates the development of non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) in male mice: Role of JNK. European Journal of Clinical Investigation. 2025 Jan;55(1):e14320. Epub 2024 Sept 29. doi: 10.1111/eci.14320
Zeng XF, Varady KA, Wang XD, Targher G, Byrne CD, Tayyem R et al. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus. Metabolism. 2024 Dec;161(2024):156028. doi: 10.1016/j.metabol.2024.156028
Sanchez Juarez VM, Baumann A, Kromm F, Yergaliyev T, Brandt A, Scholda J et al. Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD). Molecular Medicine. 2024 Oct 18;30:181. doi: 10.1186/s10020-024-00950-4
Bergheim I, Moreno-Navarrete JM. The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction-associated steatotic liver disease. European Journal of Clinical Investigation. 2024 Jul;54(7):e14224. doi: 10.1111/eci.14224
Staltner R, Valder S, Wodak M, Köpsel M, Herdegen V, Esatbeyoglu T et al. Sugar-sweetened beverage but not diluted cloudy apple juice consumption induces post-prandial endotoxemia in healthy adults. npj science of food : a natureresearch journal. 2024 Jun 21;8(1):38. doi: 10.1038/s41538-024-00283-w
Valder S, Staltner R, Bizjak DA, Esatbeyoglu T, Herdegen V, Köpsel M et al. Effect of Sugar- and Polyphenol-Rich, Diluted Cloudy Apple Juice on the Intestinal Barrier after Moderate Endurance Exercise and in Ultra-Marathon Runners. Nutrients. 2024 Apr 30;16(9). doi: 10.3390/nu16091353
Burger K, Jung F, Staufer K, Ladurner R, Trauner M, Baumann A et al. MASLD is related to impaired alcohol dehydrogenase (ADH) activity and elevated blood ethanol levels: Role of TNFα and JNK. Redox biology. 2024 Mar 12;71:103121. doi: 10.1016/j.redox.2024.103121
Jaeger J, Brandt A, Gui W, Yergaliyev T, Hernández-Arriaga A, Marutha Muthu M et al. Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression. JHEP reports. 2024 Mar;6(3):100987. doi: 10.1016/j.jhepr.2023.100987
Sanchez Juarez VM, Baumann A, Brandt A, Wodak M, Staltner R, Bergheim I. Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL/6J Mice. CMGH. 2024 Jan 21;17(5):785-800. doi: 10.1016/j.jcmgh.2024.01.009
Brandt A, Csarmann K, Hernández-Arriaga A, Baumann A, Staltner R, Halilbasic E et al. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction. The Journal of Nutritional Biochemistry. 2024 Jan;123:109495. doi: 10.1016/j.jnutbio.2023.109495
Brandt A, Hernández-Arriaga A, Yergaliyev T, Nier A, Halilbasic E, Trauner M et al. Short-term intake of fiber-rich oat bran but not spelt bran flake mix lowers bacterial endotoxin levels and improves health parameters in healthy, normal weight, young to middle-aged women. Journal of Functional Foods. 2024 Jan;112:105929. doi: 10.1016/j.jff.2023.105929
Rajcic D, Kromm F, Hernández-Arriaga A, Brandt A, Baumann A, Staltner R et al. Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice. Biomolecules. 2023 Oct 26;13(11):1579. doi: 10.3390/biom13111579
Jung F, Brandt A, Bergheim I. Intestinal barrier and pathogen-associated molecular patterns (PAMPs) in the development and therapy of alcohol-related liver disease. In Mueller S, Heilig M, editors, Alcohol and alcohol-related diseases. 1 ed. Cham: Springer. 2023. p. 1167-1183 Epub 2023 Oct 21. doi: 10.1007/978-3-031-32483-3_61
Burger K, Jung F, Baumann A, Brandt A, Staltner R, Sanchez Juarez VM et al. TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice. Redox biology. 2023 Oct;66:102870. doi: 10.1016/j.redox.2023.102870
1 - 20 out of 90

Alterations of Alcohol Dehydrogenase (ADH) Activity in MASLD Development: Mechanisms and Implications

Bergheim, I. (Speaker)

2 Oct 2025 → 3 Oct 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Impact of different alcoholic beverages on the development of alcohol associated liver diseases and immune response: beer and its compounds

Bergheim, I. (Speaker), Csarmann, K. (Contributor), Baumann, A. (Contributor) & Hellerbrand, C. (Contributor)

4 Sept 2025 → 6 Sept 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Intestinal NO-homeostasis as possible therapeutic target in the development of alcohol-related liver disease

Baumann, A. (Speaker), Brandt, A. (Contributor), Staltner, R. (Contributor) & Bergheim, I. (Contributor)

4 Sept 2025 → 6 Sept 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Alcohol-related liver disease and its association with the Toll-like receptor ligandom

Staltner, R. (Speaker), Müller, S. (Contributor) & Bergheim, I. (Contributor)

21 Jun 2025 → 25 Jun 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Impact of Juvenile Alcohol Abuse as Modulator of Aging-Related Liver Degradation

Brandt, A. (Speaker), Staltner, R. (Contributor), Schilp, C. (Contributor), Baumann, A. (Contributor) & Bergheim, I. (Contributor)

21 Jun 2025 → 25 Jun 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

TNFα als Regulator kognitiver Beeinträchtigungen bei einer diät-induzierten MASLD

Brandt, A. (Speaker), Burger, K. (Contributor), Baumann, A. (Contributor) & Bergheim, I. (Contributor)

12 Mar 2025 → 14 Mar 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Intestinale Barriere, Ernährung und Sport

Bergheim, I. (Invited speaker)

28 Feb 2025

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Nutrition as modulator of the gut-liver axis in the development of MASLD

Bergheim, I. (Speaker)

6 Dec 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Entwicklung neuer ernährungsbasierter Präventions- und Therapieansätze bei Fettlebererkrankungen

Bergheim, I. (Speaker)

11 Oct 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Nutrition, intestinal microbiota and barrier as modulators of the development of liver diseases

Bergheim, I. (Speaker)

20 Jun 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Symposium Gut, Liver, Microbiota & Lifestyle

Bergheim, I. (Speaker)

7 Jun 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Dietary sugar intake as possible trigger of liver steatosis and other diseases

Bergheim, I. (Speaker)

6 Nov 2023

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Dietary Fructose Intake: A Trigger of Liver Disease

Bergheim, I. (Speaker)

23 Oct 2023

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Metabolic Dysfunction Associated Steatotic Liver Disease (MASDL): Dietary sugar intake and intestinal NO-homeostasis as possible triggers

Bergheim, I. (Invited speaker)

7 Sept 2023

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Modulation of the intestinal NO homeostasis as trigger of intestinal barrier dysfunction in the development of alcohol-related liver disease

Baumann, A. (Speaker), Kromm, F. (Contributor), Sanchez Juarez, V. M. (Contributor), Staltner, R. (Contributor), Brandt, A. (Contributor) & Bergheim, I. (Contributor)

1 Sept 2023

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Effects of fructose and NO homeostasis on intestinal barrier function in the development of non-alcoholic fatty liver disease (NAFLD)

Bergheim, I. (Speaker)

1 Dec 2022 → 2 Dec 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Ernährungstherapie der Fettleber

Bergheim, I. (Speaker)

10 Nov 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Effect of xanthohumol on lipoteichoic acid-induced immune response in human peripheral mononuclear blood cells

Bergheim, I. (Speaker)

30 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Dietary modulation of intestinal microbiota as trigger of liver health: role of bile acids

Bergheim, I. (Speaker)

23 May 2022 → 25 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Einfluss des Neolignans Honokiol auf die intestinale Barrierefunktion

Baumann, A. (Speaker), Habersatter, E. (Contributor), Schachner, D. (Contributor), Dirsch, V. (Contributor) & Bergheim, I. (Contributor)

17 Mar 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Intestinal bacteria and bacterial endotoxin in the development and therapy of alcohol-related liver disease

Bergheim, I. (Speaker)

9 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Alcohol-related liver disease: also a matter of how and what you drink?

Bergheim, I. (Speaker)

20 Jun 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Einfluss von Saccharose und Süßstoffen auf das Körpergewicht

Bergheim, I. (Speaker)

18 Jun 2020

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Soybean oil attenuates the onset of non-alcoholic steatohepatitis and insulin resistance

Sanchez Juarez, V. M. (Selected presenter), Brandt, A. (Contributor), Engstler, A. J. (Contributor), Jin, C. J. (Contributor), Rajcic, D. (Contributor), Jung, F. (Contributor), Nier, A. (Contributor), Baumann, A. (Contributor) & Bergheim, I. (Contributor)

14 Nov 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Alcoholic liver disease: Impact of the type of alcoholic beverage

Bergheim, I. (Speaker)

23 Sept 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Fructose, ein Trigger in der Entstehung der NAFLD

Bergheim, I. (Invited speaker)

20 Sept 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Toll-Like Receptor 1: A Target in Non-Alcoholic Fatty Liver Disease?

Baumann, A. (Speaker), Nier, A. (Contributor), Hernández-Arriaga, A. (Contributor), Brandt, A. (Contributor), Jin, C. J. (Contributor), Pilar, E. (Contributor), Camarinha Silva, A. (Contributor), Schattenberg, J. M. (Contributor) & Bergheim, I. (Contributor)

29 Jun 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

What is the best mouse model to recreate physiology and pathology of human NAFLD?

Bergheim, I. (Invited speaker)

14 Apr 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

"NO, ein kritischer Faktor der intestinalen Homöostase im Alter?"

Brandt, A. (Speaker), Camarinha Silva, A. (Contributor), Jin, C. J. (Contributor), Baumann, A. (Contributor), Engstler, A. (Contributor), Nier, A. (Contributor), Rajcic, D. (Contributor), Sellmann, C. (Contributor), Schmeer, C. (Contributor), Wagner, K.-H. (Contributor), Witte, O. W. (Contributor) & Bergheim, I. (Contributor)

19 Mar 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Intestinal microbiota and barrier: a trigger of aging?

Bergheim, I. (Invited speaker)

8 Nov 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Bedeutung von Omega-3 Fettsäuren bei der Nichtalkoholischen Fettleber

Bergheim, I. (Invited speaker)

19 Oct 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Changes of intestinal microbiota and barrier function are associated with aging

Baumann, A. (Speaker), Brandt, A. (Contributor), Engstler, A. (Contributor), Jin, C. J. (Contributor), Nier, A. (Contributor), Frahm, C. (Contributor), Witte, O. W. (Contributor), Camarinha Silva, A. (Contributor) & Bergheim, I. (Contributor)

21 Sept 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Intestinal microbiota and barrier: a trigger of stress and aging?

Bergheim, I. (Invited speaker)

21 Sept 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Metformin treatment in early diet-induced non-alcoholic fatty liver disease: Role of intestinal barrier function and microbiota composition

Baumann, A. (Speaker), Brandt, A. (Contributor), Jin, C. J. (Speaker), Kehm, R. (Contributor), Sellmann, C. (Contributor), Metzger, I. (Contributor), Camarinha Silva, A. (Contributor) & Bergheim, I. (Contributor)

8 Jul 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Ernährung, Darmbarriere und Altern: eine neue Beziehung?

Bergheim, I. (Invited speaker)

23 Jun 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Nutrition, aging and liver disease

Bergheim, I. (Invited speaker)

18 May 2018 → 1 Jun 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

The gut and the liver: two of a kind?

Bergheim, I. (Invited speaker)

20 Apr 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Metabolic abnormalities in normal weight children: Role of intestinal permeability

Nier, A. (Speaker), Maier, I. B. (Contributor), Özel, Y. (Contributor) & Bergheim, I. (Contributor)

19 Apr 2018 → 20 Apr 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Non-alcoholic fatty liver disease and nutrition: Impact of dietary pattern

Bergheim, I. (Invited speaker)

26 Feb 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Neuer Forschungsschwerpunkt des Departments für Ernährungswissenschaften: Ernährungsbasierte Präventions- und Therapiestrategien bei metabolischen Lebererkrankungen

Bergheim, I. (Speaker)

9 Nov 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Effect of iso-alpha-acids, bitter acids in beer on acute alcohol induced liver injury

Bergheim, I. (Speaker)

9 Oct 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Ernährungstherapie bei Fettleber

Bergheim, I. (Speaker)

22 Oct 2016

Activity: Talks and presentations › Talk or oral contribution › Other

Die Behandlung mit Antibiotika schützt Mäuse vor der Entstehung einer akuten Western Style Diät-induzierten, nicht-alkoholbedingten Fettlebererkrankung

Brandt, A. (Speaker), Nolte, K. (Contributor), Sellmann, C. (Contributor), Jin, C. J. (Contributor), Engstler, A. J. (Contributor), Landmann, M. (Contributor) & Bergheim, I. (Contributor)

15 Oct 2015 → 17 Oct 2015

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Intestinal barrier and healthy aging

Bergheim, I. (Project Lead)

1/04/22 → 31/03/26

Project: Research funding

Xanthohumol and viral infections

Bergheim, I. (Project Lead)

1/09/21 → 28/02/26

Project: Research funding

Aging and bacterial endotoxin

Bergheim, I. (Project Lead) & Höhn , A. (Co-Lead)

1/04/21 → 31/07/25

Project: Research funding

Gut-brain-axis: Targets for improvement of cognition in the elderly

Bergheim, I. (Project Lead)

1/09/20 → 28/02/25

Project: Research funding

Endogenous Alcohol in Non-alcoholic Fatty Liver Disease

Bergheim, I. (Project Lead)

1/04/19 → 30/09/23

Project: Research funding

Department of Nutritional Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2F504

T: +43-1-4277-54981

ina.bergheim@univie.ac.at